3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sands China Ltd., Las Vegas Sands' majority-owned subsidiary, said it intends to offer USD-denominated senior unsecured notes, with terms to be set at pricing. The filing says no binding agreement exists yet and the offering may or may not happen, so shareholders have no confirmed deal or financial effect to assess.
Sands China intends to offer USD-denominated senior unsecured notes; principal amounts, interest rates and other terms will be determined at pricing.
Planned uses include redeeming in full its US$700 million 2.300% senior notes due 2027, repaying the balance on its 2024 SCL Revolving Facility, and general corporate purposes.
As of October 26, 2026, no binding agreement existed, and Sands China has an eligibility letter from the Hong Kong Stock Exchange for a proposed listing of the notes.
On October 20, 2026, iQSTEL issued senior secured, non-convertible promissory notes of up to $3 million in aggregate to M2B Funding Corp. and ADI Funding LLC, along with pre-funded warrants for 420,000 shares, to help fund its planned 51% acquisition of Ultranet Telecom Group. The notes carry 18% annual interest and are secured by a first-priority interest in company collateral, and the warrants could add dilution, so the financing adds debt cost and potential share issuance for shareholders while the acquisition itself is not yet signed.
Up to $3 million in notes, split between two purchasers: first $750,000 per purchaser funded on or about October 20, 2026, and a second advance of up to $750,000 per purchaser due on or before December 1, 2026
Notes bear 18% annual interest payable monthly in cash; principal repaid in four equal installments over 24 months
Warrants for 420,000 shares at a $0.0001 exercise price were fully issued at the initial closing; holders may accelerate at 120% of funded principal after an uncured default
Company expects to sign the Ultranet share purchase agreement in November 2026 and target closing in the middle of the first quarter of 2027
Venu Holding Corp and subsidiaries executed agreements on October 20, 2026, selling the approximately 46-acre McKinney Parcel under The Sunset McKinney to STORE Capital Acquisitions, LLC and amending its Chapter 380 agreement with the City of McKinney. The city agreement lets the company keep operating control but adds a $3,000,000 cap on certain annual operations incentives and reduces a separated materials tax grant, while the company expects to be reimbursed the full $35,000,000 land purchase price if it meets construction milestones.
Land sale to STORE and the McKinney Sale-Leaseback closed on October 20, 2026, the Execution Date.
The company expects reimbursement of the full $35,000,000 land price ($10,000,000 cash plus $25,000,000 MEDC Note) if a TCO is received by December 3, 2027, or a CO by June 3, 2028.
Certain annual operations incentives for years 12 through 16 are capped at $3,000,000 in aggregate.
The filing excerpt does not state the sale-leaseback sale price.
On October 26, 2026, West Pharmaceutical Services entered a new credit agreement with Bank of America as administrative agent. It includes a $750 million revolving facility and a $200 million term loan advanced on the effective date, and the company used the borrowings to repay $130.0 million outstanding under its 2019 credit agreement, which it terminated with no early termination penalties. The filing reports no change to earnings or guidance, but it sets new debt terms, including a maximum net leverage ratio of 3.50 to 1.0.
New credit agreement provides a $750 million revolving facility and a $200 million term loan, with a five-year term from October 26, 2026.
$130.0 million outstanding under the 2019 credit agreement was repaid in full on October 26, 2026, with no early termination penalties.
Borrowings are unsecured; the net leverage covenant caps the ratio at 3.50 to 1.0, or 4.00 to 1.0 during material acquisition periods.
Term loan quarterly amortization starts March 31, 2028, at $1.25 million to $2.5 million per quarter, with the balance due at maturity.
Equillium said on October 26, 2026 that it dosed the first subject in its Phase 1 trial of EQ504 in Australia, which triggered the Milestone Closing of its August 2025 private placement. The company sold 14,957,260 shares at $0.57 and 20,130,457 pre-funded warrants at $0.5669 for gross proceeds of about $20.0 million before fees. The sale adds to the share count, and the company must file resale registration statements within 30 days, with cash penalties for registration failures.
Milestone Closing on October 26, 2026: 14,957,260 shares at $0.57 and 20,130,457 pre-funded warrants at $0.5669 each.
Gross proceeds of about $20.0 million before fees; total equity private placement proceeds of about $50 million.
Investors waived the $2.50 weighted average price threshold on October 26, 2026.
Registration statements for resale must be filed within 30 days of the Milestone Closing, with cash penalties for registration failures.
Eva Live said Streeterville Capital asserted that the company's October 2, 2026 Dune Equity Holdings deal breached the terms of two convertible notes, triggering a 10% increase in their outstanding balances. The company estimates the increase at about $741,786, raising the total to about $8,159,643, and disputes the lender's position and reserves all rights. Shareholders face potential added debt and possible legal or enforcement action, and the outcome is uncertain.
Streeterville's October 20, 2026 letter asserts a Major Trigger Event under each note as of October 2, 2026, and says the outstanding balances rose 10%.
The company estimates the balance would rise from about $7,417,857 to about $8,159,643, including about $522,302 on the February note and about $219,483 on the July note.
Streeterville has not delivered a cure demand or declared an Event of Default, according to the filing.
The company disputes the lender's assertions and says it is evaluating its options, which may include legal proceedings.
Supernus Pharmaceuticals terminated its uncommitted UBS revolving credit line on October 20, 2026, in connection with its planned business combination with Indivior Pharmaceuticals and a new senior secured credit facility for the combined company. The company reported no outstanding borrowings and no early termination penalties, so the termination itself has no direct financial cost disclosed in the filing.
Terminated UBS Credit Line Agreement dated February 8, 2023, with UBS Bank USA on October 20, 2026
No advances, letters of credit or other borrowings were outstanding at termination
No early termination penalties were incurred; the Bank's security interests in the collateral were released
Termination tied to the pending combination with Indivior Pharmaceuticals under a merger agreement dated August 1, 2026
Fidus Investment Corporation closed an exchange offer on October 20, 2026, swapping $120.0 million of privately issued 6.625% notes due 2029 for registered notes with the same principal and terms. The filing confirms the notes are unsecured obligations that mature June 1, 2029, and the holders' principal amount is unchanged, so the exchange itself does not add new debt.
Exchange offer closed October 20, 2026; holders now hold the same $120.0 million principal in registered Exchange Notes
Notes bear 6.625% annual interest, paid semi-annually on June 1 and December 1, starting December 1, 2026, and mature June 1, 2029
Notes are unsecured and rank pari passu with existing unsecured debt, including the 6.750% notes due 2030; effectively and structurally subordinated to secured debt and subsidiary obligations
Unitil's subsidiary Maine Natural Gas issued $40 million of 5.95% senior unsecured notes due October 21, 2031, and the parent repaid all outstanding amounts under its Bank of Nova Scotia credit agreement on October 22, 2026. The notes are intended to refinance existing company debt and for general corporate purposes, and the repayment of the credit facility is a financing refinancing step with no reported change in earnings or guidance.
Maine Natural Gas Corporation sold $40,000,000 of 5.95% Senior Unsecured Notes due October 21, 2031, under a Note Purchase Agreement dated October 21, 2026.
Unitil repaid all outstanding amounts under its Amended and Restated Credit Agreement with The Bank of Nova Scotia on October 22, 2026, without premium or penalty.
The credit agreement had a borrowing limit of $86.0 million for tranche A and $50.0 million for tranche B, and the company may not reborrow repaid amounts.
Net proceeds are planned for refinancing existing debt of the company and/or general corporate purposes.
Rent the Runway completed its previously announced $15,000,000 rights offering on October 20, 2026. Subscribers bought 2,501,262 Class A shares for about $8.9 million, and an investor group bought the unsubscribed shares at $3.55 each for about $6.1 million, so the company issued new shares that increase the total number outstanding.
Rights offering completed October 20, 2026, with subscribers exercising rights for 2,501,262 Class A shares and gross proceeds of about $8.9 million
Investor Group (CHS US Investments LLC, Gateway Runway, LLC and S3 RR Aggregator, LLC) bought unsubscribed shares at $3.55 per share under a backstop agreement
On October 21, 2026, the company issued 1,724,089 Class A shares under the backstop commitment, for gross proceeds of about $6.1 million
Host Hotels & Resorts, through its operating partnership Host LP, entered into a restated senior unsecured credit agreement on October 21, 2026, replacing facilities that were due in January 2027 and January 2028. The filing describes the new revolver and term loans as maturing in January 2031 and January 2032, with pricing tied to the company's debt rating and a leverage-based pricing adjustment, and covenants substantially the same as before.
Revolver of $1.5 billion replaced with a new revolver in the same committed amount, maturing January 15, 2031, with extension options
Two term loans of $500 million each refinanced: Term A-1 maturing January 15, 2031 and Term A-2 maturing January 15, 2032
As of October 21, 2026, $500 million was outstanding under each term loan and no revolver borrowings other than existing letters of credit
Financial covenants are substantially the same as the prior agreement, including a leverage ratio not exceeding 7.25:1.00
BranchOut Food Inc. (Nasdaq: BOF) sold 2,941,177 new shares of common stock at $1.70 per share in an underwritten public offering that closed on October 26, 2026, with approximately $4.6 million in net proceeds. The company plans to use the proceeds for working capital and general corporate purposes, including operating expenses and capital expenditures. Issuing these new shares increases the number of shares outstanding, which dilutes existing shareholders' ownership.
Offering of 2,941,177 shares at $1.70 per share, with gross proceeds of about $5.0 million
Net proceeds of approximately $4.6 million after underwriting discounts, legal fees and offering expenses; closed October 26, 2026
Underwriter Lake Street Capital Markets LLC received a 30-day option to buy up to 441,176 additional shares
Underwriting discount of 7.0% on gross proceeds; officers and directors agreed to a 90-day lockup on share sales
UFP Industries amended its credit agreement, extending the maturity of its $750 million revolving credit facility to October 23, 2031. The company also agreed to acquire the operating assets of Apache Products, Inc. for approximately $27 million, with closing expected on or around November 16, 2026.
Fifth Amendment, effective October 23, 2026, extends the $750 million revolver to October 23, 2031.
As of September 26, 2026, no cash borrowings were outstanding and about $42 million of letters of credit were outstanding.
Apache Products, a Silsbee, Texas pallet maker, is being acquired for approximately $27 million and adds about $55 million in annual sales and 165 employees.
The acquisition is expected to close on or around November 16, 2026, subject to customary closing conditions.
AAR CORP. entered into Amendment No. 3 to its revolving credit facility on October 23, 2026, increasing total commitments from $825 million to $1.375 billion and extending maturity to October 2031. The amendment also expressly permits the company's pending acquisition of a controlling interest in MRO Holdings, which the filing says is not a condition of the amendment taking effect.
Total commitments increased to $1.375 billion, up $550 million from $825 million.
Maturity extended from December 2027 to October 2031, the fifth anniversary of the amendment closing date.
Maximum leverage ratio raised to 5.50 to 1.00, with step-downs over time; minimum interest coverage ratio decreased to 2.00 to 1.00.
Amendment expressly permits the pending MROH Acquisition of a controlling interest in MRO Holdings, Inc.
Peraso Inc. agreed on October 26, 2026 to sell shares, pre-funded warrants and common warrants to Nant Capital, LLC for expected gross proceeds of about $10 million, before offering expenses. The deal, expected to close on or about October 28, 2026, adds cash but also issues a large number of new shares and warrants, which would dilute existing shareholders. It also gives Nant the right to designate board members while its stake stays at or above 5% of outstanding common stock.
Units priced at $0.5034, including Shares, Pre-Funded Warrants and Common Warrants; 3,271,355 shares and pre-funded warrants for 16,593,563 shares, plus common warrants for up to 19,864,918 shares
Common warrants have an exercise price of $0.3784 per share and a two-year term from issuance
Nant may designate two board members while it owns at least 16.7% of common stock, and one while it owns at least 5% but less than 16.7%; no designee has been appointed yet
Closing expected on or about October 28, 2026, subject to closing conditions; proceeds are for working capital and general corporate purposes
Azitra said it will not sell shares under its at-the-market offering program with A.G.P./Alliance Global Partners for the foreseeable future. From September 28 through October 26, 2026, the company sold 1,000 shares for approximately $126 in gross proceeds, and it may resume sales or pursue other financing at any time. The same day, it released ex vivo study results for its ATR-COSF cosmetic candidate and said first-in-human initial results are expected by year end.
From September 28 through October 26, 2026, Azitra sold 1,000 shares under the ATM Program for aggregate gross proceeds of approximately $126.
On October 26, 2026, the company decided not to use the ATM Program for the foreseeable future, citing capital resources, upcoming operational milestones, the recent trading price and dilution to existing stockholders.
The company may resume ATM sales or pursue other financing transactions at any time and gave no assurance as to whether or when it will do so.
The same-day press release reported ex vivo data for ATR-COSF; detailed data are to be presented at BIO-Europe in Cologne on November 10, 2026, and first-in-human initial data are expected by year end.
On October 24, 2026, the company entered into a binding commitment letter for a master finance lease with an entity managed by Apollo Global Management, which will acquire and lease GPU pods and related equipment for company-selected data centers. The company expects aggregate principal payments under the lease schedules to total approximately $40 billion, which is a large long-term financing obligation. The deal is subject to closing conditions and is expected to close before year end, so its terms and timing could still change.
Binding commitment letter dated October 24, 2026 for a master finance lease with an entity managed by Apollo Global Management
Expected aggregate principal payments of approximately $40 billion over the lease schedules
Each tranche has a lease term of about five to five and one-quarter years, with quarterly rent paid in advance at a fixed rate to be set at pricing
Closing is expected before year end 2026; lease schedules are expected to commence in the first half of 2027 upon GPU delivery
Strive entered a sales agreement with seven agents that lets it sell up to $1.0 billion of its 15.00% Series A Perpetual SATS Preferred Stock over time through an at-the-market offering. The company has no obligation to sell any shares and may suspend or end the program at any time, and it says proceeds may go toward bitcoin purchases, acquisitions, dividends, buybacks or debt repayment, among other uses. Shareholders may face dilution if shares are sold under the program.
Sales agreement dated October 26, 2026 with seven agents, including Cantor Fitzgerald & Co. and Barclays Capital Inc.
Aggregate sales price of up to $1,000,000,000 under the ATM Offering, with agent commissions of up to 2.0% of gross proceeds.
Shares are issued under a prospectus supplement filed October 26, 2026 on an existing Form S-3 (File No. 333-290252) effective September 15, 2025.
Strive has no obligation to sell any shares and may suspend or terminate the offering at any time.
Soluna Holdings said it repaid in full the $28.7 million in principal outstanding as of June 30, 2026, under its credit facility with Generate Capital, PBC, and the facility has been terminated. The company said the liens on the related project assets have been released, and that total debt principal falls from $37.9 million at June 30, 2026 to $9.2 million, reflecting remaining balances as of that date. The filing contains no income statement or guidance figures.
$19.1 million of Generate debt was repaid in August 2026, and the remainder was paid in October 2026.
The Generate facility was terminated and liens on related project assets were released.
The company states total debt principal falls from $37.9 million at June 30, 2026 to $9.2 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.